Krilogy Financial’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Krilogy Financial’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-186	Closed	-$10K	–	842
2017 Q4	$10K	Buy	186 +21	+13%	+$1.15K	﹤0.01%	528
2017 Q3	$9K	Hold	165	–	–	﹤0.01%	597
2017 Q2	$10K	Buy	+165	New	+$9.4K	﹤0.01%	537

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Krilogy Financial's BIVV Position: Q1 2018 in Review

Krilogy Financial sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 186 shares — an estimated $10K sold.

Krilogy Financial first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $10K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Krilogy Financial reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Krilogy Financial sold 186 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $10K.
Krilogy Financial first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Krilogy Financial's Bioverativ Inc. Common Stock position peaked at $10K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Krilogy Financial's 13F filing for Q1 2018, filed 15 May 2018.